FDA OKs Gamifant, First Drug for Rare Immune Disease HLH

Emapalumab is an interferon gamma-blocking antibody that fills an unmet medical need for patients with primary hemophagocytic lymphohistiocytosis, the FDA says.
FDA Approvals

https://ift.tt/2A7bfid